Articles

The COVID-19 pandemic has put immense pressure on both individuals with T1D, and the organizations who provide them with vital supplies and medications. While there’s no doubt that people with T1D face a more uncertain and risk-filled future as we navigate quarantine and social distancing, there have been some promising steps from several sides that have …

The ongoing outbreak of the novel respiratory disease COVID-19 has become a significant threat to global health and individuals with pre-existing medical conditions. To gain a deeper understanding of how the coronavirus is affecting people with type 1 diabetes, T1D Exchange is leading a first-of-its-kind COVID-19 research surveillance study in partnership with more than 50 …

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

t1D exchange is launching a surveillance study of patients with COVID-19 and diabetes

T1D Exchange today announced the launch of a population health surveillance study of individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). The results of the study will be used to better understand the etiology and potential outcomes in COVID-19 patients and inform future clinical quality improvement activities to better respond to the global pandemic.

Lately, we are inundated with negative reports and information surrounding the Coronavirus outbreak. Fortunately, there is some good news for people with type 1 diabetes. Eli Lilly announced that beginning April 6, 2020, and for $35.00 dollars a month regardless of having a health insurance plan or not having health insurance at all, people with …

The last few weeks have been a harrowing experience for thousands of people around the world. The public health crisis caused by the novel coronavirus COVID-19 threatens to overwhelm doctors and hospitals with an alarming number of deaths and infections.

As the novel coronavirus COVID-19 continues to spread in the United States, many people are understandably concerned about access to their medications. Health officials and medical professionals working in federal, state and local governments recommend that high-risk individuals with underlying health conditions such as Type 1 Diabetes, stock up on their prescription medications, in addition to practicing basic hygiene and avoiding crowded places.

With the COVID-19 coronavirus continuing to spread and disrupt daily life, supply chains and medical operations, there is an increasing need for access to vital basics such as hand sanitizer. Through an ongoing partnership with MassBio, we were able to answer the call – along with numerous other organizations – as to how we can …

People living with type 1 diabetes learn, in many ways, to be research scientists and investigators of their own lives. We learn how slices of pizza or a plate of spaghetti affects our blood sugar, and how to mediate those effects with multiple boluses of insulin or a long-lasting dose. We discover precisely how much sugar we need to stay steady during an intense workout session. In doing so, we begin to learn about the meaning and applications of real-world data and evidence. Modern medical and scientific research takes several different approaches to investigation, from randomized, controlled clinical trials to longitudinal, observational studies that examine how people live with various conditions and therapies in the real world.

image of a monitor with COVID-19 corona virus

The most widely-reported and potentially momentous story of the moment is the novel COVID-19 coronavirus, a respiratory pathogen that has already infected at least 100,000 people around the globe and killed at least 4,300.